Sorbitol China News 202408 (12 issues per year)
On 8 Aug., Weixinkang Medicine announced that its wholly-owned subsidiary, Baiyi Pharma, had received a notification letter from the
NMPA, approving to proceed with clinical trials for its mannitol sorbitol injection
NMPA, approving to proceed with clinical trials for its mannitol sorbitol injection
Editor's Note
Market Dynamics
Baiyi Pharma receives approval for clinical trials of mannitol sorbitol injection
Tianli Pharma net profit soars in H1 2024
CSPC vitamin C sales sip 5.4% in H1 2024
Shandong Fukuan plans to set up functional sugar industrial park
Qingyuan Mingli prepares for toothpaste and mouthwash production line
Analysis on China sorbitol exports in July 2024
Price Update
China's ex-works prices of sorbitol, Aug. 2024
Market Dynamics
Baiyi Pharma receives approval for clinical trials of mannitol sorbitol injection
Tianli Pharma net profit soars in H1 2024
CSPC vitamin C sales sip 5.4% in H1 2024
Shandong Fukuan plans to set up functional sugar industrial park
Qingyuan Mingli prepares for toothpaste and mouthwash production line
Analysis on China sorbitol exports in July 2024
Price Update
China's ex-works prices of sorbitol, Aug. 2024
More Publications
Production of Functional Oligosaccharides in China 2014–2016
US$ 4,860.00
September 2017
35 pages
Crop Farming China E-News 202408 (12 issues per year)
US$ 1,620.00
August 2024
11 pages
Survey of Colloidal Silica in China
US$ 29,674.00
December 2013
113 pages
China Fluoride Materials Monthly Report 202408 (12 issues per year)
US$ 3,564.00
August 2024
32 pages
China Li-ion Battery E-News 202408 (12 issues per year)
US$ 2,916.00
August 2024
29 pages
